{"title":"Porphyrin-Based Carbon Dots: Navigating the Nanoscale Frontier of Precision Biomedicine.","authors":"Qian He","doi":"10.1002/bit.70032","DOIUrl":null,"url":null,"abstract":"As natural aromatic macrocyclic compounds with an 18-π electron system, porphyrins exhibit key values in multiple fields such as biosensing, imaging, and photothermal/photodynamic therapy due to their unique photophysical properties and chemical tunability. Their integration with low-toxicity carbon dots (CDs) with tunable optical and physicochemical properties has opened diverse innovative pathways for interdisciplinary nanotechnology research. This review presents a critical analysis of porphyrin-based CDs (p-CDs), highlighting their structural versatility and transformative applications in nanomedicine. By integrating porphyrin's photophysical prowess with CDs' biocompatibility, these hybrid materials enable breakthroughs in near-infrared bioimaging, enzymatic-optical dual sensing, and synergistic phototherapies. Synthetic strategies, including covalent π-conjugation, natural precursor carbonization, and metal-nanozyme engineering, are discussed to underscore their structure-activity relationships. In the landscape of biomedicine, p-CDs have emerged as a revolutionary tool, facilitating early disease detection, precise molecular diagnosis, and targeted therapeutic interventions, thereby reshaping the paradigms of clinical practice and patient care. However, challenges remain in large-scale production and biocompatibility assessment. Future research should prioritize biomimetic design and multimodal integration to realize the full potential of p-CDs in precision medicine.","PeriodicalId":9168,"journal":{"name":"Biotechnology and Bioengineering","volume":"119 1","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology and Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1002/bit.70032","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
As natural aromatic macrocyclic compounds with an 18-π electron system, porphyrins exhibit key values in multiple fields such as biosensing, imaging, and photothermal/photodynamic therapy due to their unique photophysical properties and chemical tunability. Their integration with low-toxicity carbon dots (CDs) with tunable optical and physicochemical properties has opened diverse innovative pathways for interdisciplinary nanotechnology research. This review presents a critical analysis of porphyrin-based CDs (p-CDs), highlighting their structural versatility and transformative applications in nanomedicine. By integrating porphyrin's photophysical prowess with CDs' biocompatibility, these hybrid materials enable breakthroughs in near-infrared bioimaging, enzymatic-optical dual sensing, and synergistic phototherapies. Synthetic strategies, including covalent π-conjugation, natural precursor carbonization, and metal-nanozyme engineering, are discussed to underscore their structure-activity relationships. In the landscape of biomedicine, p-CDs have emerged as a revolutionary tool, facilitating early disease detection, precise molecular diagnosis, and targeted therapeutic interventions, thereby reshaping the paradigms of clinical practice and patient care. However, challenges remain in large-scale production and biocompatibility assessment. Future research should prioritize biomimetic design and multimodal integration to realize the full potential of p-CDs in precision medicine.
期刊介绍:
Biotechnology & Bioengineering publishes Perspectives, Articles, Reviews, Mini-Reviews, and Communications to the Editor that embrace all aspects of biotechnology. These include:
-Enzyme systems and their applications, including enzyme reactors, purification, and applied aspects of protein engineering
-Animal-cell biotechnology, including media development
-Applied aspects of cellular physiology, metabolism, and energetics
-Biocatalysis and applied enzymology, including enzyme reactors, protein engineering, and nanobiotechnology
-Biothermodynamics
-Biofuels, including biomass and renewable resource engineering
-Biomaterials, including delivery systems and materials for tissue engineering
-Bioprocess engineering, including kinetics and modeling of biological systems, transport phenomena in bioreactors, bioreactor design, monitoring, and control
-Biosensors and instrumentation
-Computational and systems biology, including bioinformatics and genomic/proteomic studies
-Environmental biotechnology, including biofilms, algal systems, and bioremediation
-Metabolic and cellular engineering
-Plant-cell biotechnology
-Spectroscopic and other analytical techniques for biotechnological applications
-Synthetic biology
-Tissue engineering, stem-cell bioengineering, regenerative medicine, gene therapy and delivery systems
The editors will consider papers for publication based on novelty, their immediate or future impact on biotechnological processes, and their contribution to the advancement of biochemical engineering science. Submission of papers dealing with routine aspects of bioprocessing, description of established equipment, and routine applications of established methodologies (e.g., control strategies, modeling, experimental methods) is discouraged. Theoretical papers will be judged based on the novelty of the approach and their potential impact, or on their novel capability to predict and elucidate experimental observations.